| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 244,401 | 238,439 | 224,719 | 260,364 | | Cost of Revenue | 184,367 | 177,359 | 193,507 | 243,837 | | | Gross Profit | 60,034 | 61,080 | 31,212 | 16,527 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 62,171 | 49,603 | 54,654 | 54,307 | | Non Recurring | 1,564 | 1,213 | 108,732 | 520,107 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,701) | 10,264 | (132,174) | (557,887) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (98,697) | 751 | 488 | (122) | | Earnings Before Interest And Taxes | (102,398) | 11,015 | (131,686) | (558,009) | | Interest Expense | 7,381 | 4,369 | 4,052 | 4,608 | | Income Before Tax | (109,779) | 6,646 | (135,738) | (562,617) | | Income Tax Expense | (7,661) | 2,675 | (15,531) | (34,007) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (202,378) | 3,971 | (120,207) | (528,610) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (102,118) | 3,971 | (120,207) | (528,610) | | Preferred Stock And Other Adjustments | (11,713) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($113,831) | $3,971 | ($120,207) | ($528,610) |
|
0.24% Nasdaq 
0.36%
Income Statement
